Journal
NEUROSCIENCE LETTERS
Volume 767, Issue -, Pages -Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.neulet.2021.136289
Keywords
Neuroscience; Dopamine; Dopamine receptors; Astrocytes; Huntington's disease; Neurodegeneration; Dopamine D2 receptor
Categories
Funding
- NIHR Cambridge Biomedical Research Centre [BRC-1215-20014]
- Cambridge Brain Bank
Ask authors/readers for more resources
The research found that the expression of D2 receptors on astrocytes is reduced in Huntington's disease, indicating a potential importance of astrocytes in the DA-dependent aspects of the disease. Further studies are needed to determine the functional significance of this finding.
Dysfunction of the central dopaminergic system is thought to contribute to some of the clinical features of Huntington's disease (HD), and dopamine (DA) receptor antagonists are commonly used to good effect in its treatment. It is well established that there is an early significant reduction in neuronal D2 receptors in HD, considered to be a compensatory response to increased dopaminergic activity. However, no studies have examined the expression of D2 receptors on astrocytes which is important given that these cells have been shown to play a role in the pathogenesis of HD, as well as express dopamine receptors and modulate DA homeostasis in the normal brain. We therefore sought to investigate the expression of D2 receptors on astrocytes in HD, and found them to be reduced in both the R6/1 HD mouse model, and in human post-mortem brain in comparison to controls, suggesting that astrocytes may be important in DA-dependent aspects of HD. Further studies are needed to determine the functional significance of this finding.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available